newborn screening doc. mudr. marie Čern, csc. lecture no 423-h
DESCRIPTION
Its performance It is based on the analysis of dry drop of blood bound to the filter paper – so- called the newborn screening card. Blood is sampling under defined conditions from all newborns born in the region of the Czech Republic (the 48 th -72 nd hour of life).TRANSCRIPT
Newborn screening
Doc. MUDr. Marie Černá, CSc.
Lecture No 423-H
What is screening programme?
Newborn screening (NS) is an active and nation-wide searching of diseases during their early, preclinical periods so as to diagnose and treat these diseases before their clinical manifestations and subsequently irreversible health damage of newborns.
Its performance
It is based on the analysis of dry drop of blood bound to the filter paper – so-called the newborn screening card. Blood is sampling under defined conditions from all newborns born in the region of the Czech Republic (the 48th -72nd hour of life).
Sampling of blood dry drop
Sampling of blood dry drop
Sampling of blood dry drop
time sampling(the 48th – 72nd hour)
sample shipment every working day into 2 laboratories
acquainted approval
34
44
44 45
50
53
35
51
50
32
4147
46
37
29
29
4148
40
DC
51 1331
45
35
33
36
2929
50
41
48
31
45
33 45
48
52
31
31
35
54 49
32
5049
24
31
31
46
49
51
52
32
5252
31
30
Source: US National Newborn Screening Network, public domain, no copyrights
Numbers of tested diseasesin the U.S.A. (state in 2008):
Source: International Society for Neonatal Screening (ISNS)
Numbers of tested diseasesin Europe (state in 2009):
13 diseases are tested in the Czech Republic from 1.10.2009:
congenital decreased function of thyroid gland(congenital hypothyroidism - CH)
congenital insufficiency of hormone production in adrenal glands (congenital adrenal hyperplasia - CAH)
congenital disorder of mucus production (cystic fibrosis - CF)
4 hereditary disturbances of amino acid metabolism 6 hereditary disorders of fatty acid oxidation
Congenital adrenal hyperplasia
Cystic fibrosis
Phenylketonuria
– congenital disturbance of amino acid metabolism of phenylalanine (phenylketonuria - PKU and hyperphenylalaninemia - HPA)
– congenital disturbance of metabolism of branching amino acids (leucinosis, Maple syrup urine disease - MSUD)
– glutaric aciduria type I (GA I) – isovaleric aciduria (IVA)
Hereditary disturbances of amino acid metabolism
Hereditary disorders of fatty acid oxidation
– medium chain acyl-CoA dehydrogenase deficiency (MCAD deficiency)
– long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD deficiency)
– very long chain acyl-CoA dehydrogenase deficiency (VLCAD deficiency)
– carnitine palmitoyl transferase I deficiency (CPT I d.) – carnitine palmitoyl transferase II deficiency (CPT II d.) – carnitine-acylcarnitine translocase deficiency (CACT d.)
